Agios Pharmaceuticals, Inc.

LSE (USD): Agios Pharmaceuticals, Inc. (0HB0)

Last Price

44.20

Today's Change

+5.60 (14.50%)

Day's Change

42.20 - 44.20

Trading Volume

10

Overview

Market Cap

2 Billion

Shares Outstanding

58 Million

Avg Volume

522

Avg Price (50 Days)

26.18

Avg Price (200 Days)

24.83

PE Ratio

-6.88

EPS

-6.43

Earnings Announcement

30-Oct-2025

Previous Close

38.60

Open

42.20

Day's Range

42.2 - 44.2

Year Range

20.13 - 44.2

Trading Volume

14

Price Change Highlight

1 Day Change

14.51%

5 Day Change

15.25%

1 Month Change

52.84%

3 Month Change

29.13%

6 Month Change

33.70%

Ytd Change

32.06%

1 Year Change

-0.52%

3 Year Change

42.17%

5 Year Change

29.39%

10 Year Change

-45.24%

Max Change

-45.24%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Pharmaceuticals, Biotechnology & Life Sciences

Description:

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments

{uid}

{comment}

Just now

Post a Comment